A Pharmacokinetic Study of Gecacitinib Hydrochloride Tablets in Healthy Adult Participants.

Phase 1 Active not recruiting 64 enrolled Suzhou Zelgen Biopharmaceuticals Co.,Ltd

RandomizedCrossoverOpen-labelTreatment

Summary

This study will compare the pharmacokinetics (PK) effect of two different formulations of Gecacitinib Hydrochloride Tablets in healthy Adult participants

Timeline

Start: 2026-05-12
Primary completion: 2027-02
Completion: 2027-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gecacitinib	Unknown	75 mg	Oral

Indications

No indication recorded.